Dessintey lève 1 M€ pour accélérer la commercialisation en Europe de l’IVS3

19 juin 2019

Dessintey lève 1 M€ pour accélérer la commercialisation en Europe de l’IVS3, son innovation pour la rééducation post AVC.
Dessintey, startup MedTech, annonce une levée de fonds de 1 million d’euros auprès de Sham Innovation Santé, du Crédit Agricole Loire Haute Loire Capital Innovation et d’un investisseur privé, professionnel de la santé.

Télécharger le communiqué de presse (pdf 1.2 Mo)).

Autres actualités

Our partners speak about us

Our partners speak about us

Freyming Merlebach Hospital 🇫🇷, specialized in rehabilitation, is now equipped with IVS4, dedicated to lower limb rehabilitation.The hospital team talks about Dessintey’s unique technology in the daily newspaper Le Républicain Lorrain. 📰...

lire plus
What is the link between Mickael Phelps and stroke patients?

What is the link between Mickael Phelps and stroke patients?

Have you ever listened to the World's best swimmer speaking about how he visualises his races and imagines himself winning? He uses a specific training technic: mental imagery. 🧠 Based on strong scientific background, mental imagery is very useful for stroke patients...

lire plus
Dessintey joins the 🇫🇷 French Healthcare Association!

Dessintey joins the 🇫🇷 French Healthcare Association!

We are glad to announce the company just joined the French Healthcare Association.This association aims at promoting French health industries on international markets. 🔹 Medical industries,🔹 Health establishments,🔹 Research and training centers,🔹 Pharmaceutical...

lire plus